RPS partnership agreement with LFI

09 Oct 2015
On the 30th of September, the Royal Pharmaceutical Society (RPS) and The Pharmaceutical Society of Iceland (Lyfjafræðingafélag Íslands - LFI)
signed a Memorandum of Understanding at the 2015 International Pharmaceutical Federation (FIP) World Congress in Dusseldorf, Germany, to support developing a long-term collaborative partnership between the RPS and LFI.  
The two organisations share a common vision for the development and recognition of a quality driven workforce in pharmacy with many activities already aligned. Shared work streams have been identified that will deliver a wide international agenda for the benefit of the professions, patients and the public. 
The aim of the partnership agreement is to underpin joint working for the mutual benefit of both parties, their members and stakeholders and the wider profession of pharmacy across our two nations. 
The organisations will identify joint or shared objectives for collaboration in order to achieve the best outcome for both parties, the professions and patients and the public.  These will include joint working on Foundation training (through RPS accredited Foundation Schools); Professional Development and Recognition programmes through RPS Faculty membership and assessment; Sharing of best practice around new models of care; and prescribing and frameworks, through the review of the prescribing framework (led by RPS in the UK).
During his address, Mr Ashok Soni OBE, President of the RPS, said this was further evidence that joint working and partnerships between nations can enhance professional development and was “a significant step in demonstrating that international cooperation is both possible and desirable and an outstanding example of joint leadership.”  Lóa María Magnúsdóttir, President of the LFI, indicated that the aim was to “unite both national associations with a common purpose”.  She further said that the profession in Iceland was collectively looking forward to seeing progress and our collaborations working in practice.  
The signing event was held during the RPS Reception at the 75th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Dusseldorf, and the Memorandum was signed by Presidents of both organisations, Ashok Soni OBE (RPS) and Lóa María Magnúsdóttir (LFI), together with RPS Chief Executive, Helen Gordon and LFI Chief Executive Sigriður Siemsen.
In a further signing event, the University if Iceland, represented by Professor Hakon Hrafn Sigurdsson, and the Landspitali National University Hospital of Iceland, represented by Ms Inga Arnardóttir, Chief Pharmacist, also signed an Memorandum with RPS, which set out programme to provide Foundation training support and Advanced practice training, linked to the RPS Faculty professional recognition.  This follows from an initiative started by Freyja Jónsdóttir, a clinical pharmacist who trained in London, and facilitation conducted by UCL as part of a global interest in professional leadership and transnational education and training.
Prof William Charman, Chair of FIP Education Initiative, said "The recently launched RPS Vision for the workforce is an impressive document that advances and re-frames aspects of our practice in the context of patients and the broader healthcare community. The FIP Education Initiative, and pharmacy member organisations globally, will undoubtedly emulate aspects of this unique piece of work in the context of their practice and societal needs."